Article
Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study.
Blood - 11 Aug 2011
Moratto Daniele, Giliani Silvia, Bonfim Carmem, Mazzolari Evelina, Fischer Alain, Ochs Hans D, Cant Andrew J, Thrasher Adrian J, Cowan Morton J, Albert Michael H, Small Trudy, Pai Sung-Yun, Haddad Elie, Lisa Antonella, Hambleton Sophie, Slatter Mary, Cavazzana-Calvo Marina, Mahlaoui Nizar, Picard Capucine, Torgerson Troy R, Burroughs Lauri, Koliski Adriana, Neto Jose Zanis, Porta Fulvio, Qasim Waseem, Veys Paul, Kavanau Kristina, Hönig Manfred, Schulz Ansgar, Friedrich Wilhelm, Notarangelo Luigi D
Abstract excerpt
In this retrospective collaborative study, we have analyzed long-term outcome and donor cell engraftment in 194 patients with Wiskott-Aldrich syndrome (WAS) who have been treated by hematopoietic cell transplantation (HCT) in the period 1980- 2009. Overall survival was 84.0% and was even higher (89.1% 5-year survival) for those who received HCT since the year 2000, reflecting recent improvement of outcome after...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.